Resurgent Financial Advisors LLC Novo Nordisk A S Transaction History

Resurgent Financial Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $105,071 - $139,861	1,029 Added 184.41%	1,587 $203,000
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $1,580 - $1,898	18 Added 3.33%	558 $57,000
Q3 2023 Nov 13, 2023	SELL	$90.94 - $199.54 $15,732 - $34,520	-173 Reduced 24.26%	540 $49,000
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $29,480 - $32,630	-189 Reduced 20.95%	713 $115,000
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $1,058 - $1,273	-8 Reduced 0.88%	902 $143,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $93,320 - $123,150	910 New	910 $123,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $252B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resurgent Financial Advisors LLC with notifications on news.